AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

16 recruiting trials

for Malignant Peritoneal Effusion

Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant Ascites NCT07149090Phase 1, Phase 21 site๐Ÿ“ Seoul Asan Medical Center ยท Tests: Lenvatinib APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion NCT04919629Phase 21 site๐Ÿ“ Buffalo Roswell Park Cancer Institute ยท Tests: Bevacizumab, Biopsy, Biospecimen Collection, Pegcetacoplan, Pembrolizumab A Clinical Study of GK02 in Malignant Ascites NCT07378436EARLY Phase 11 site๐Ÿ“ Beijing Beijing Geekgene Technology Co., LTD ยท Tests: GK02 At-Home Paracentesis for Cancer-Related Malignant Ascites (Paracentesis) NCT07490626NA1 site๐Ÿ“ Salt Lake City University of Utah ยท Tests: At-home Paracentesis Dual-targeting VEGFR1 and PD-L1 CAR-T for Pleural, Peritoneal, or Leptomeningeal Metastases NCT05477927Phase 11 site๐Ÿ“ Chengdu Sichuan University ยท Tests: Dual-targeting VEGFR1/PD-L1 CAR-T cells A Clinical Trial With Apatinib for Subjects With Refractory Malignant Ascites NCT03020979Phase 21 site๐Ÿ“ Bengbu The First Affiliated Hospital of Bengbu Medical University ยท Tests: Apatinib Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites NCT06759064Phase 1, Phase 21 site๐Ÿ“ Jinan Qilu Hospital of Shandong University ยท Tests: zoledronic acid plus Sintilimab intraperitoneal injection Anti-PD-1 in Combination With Systemic Chemotherapy With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites NCT07855640n/a1 site๐Ÿ“ Hangzhou Zhejiang Cancer Hospital NK521 in the Treatment of Malignant Ascites Associated With Advanced Solid Tumors NCT07561437EARLY Phase 11 site๐Ÿ“ Beijing Base Therapeutics (Shanghai) Co., Ltd. ยท Tests: NK521 Cell Injection GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites NCT05438459Phase 1, Phase 21 site๐Ÿ“ Fukuoka Kyushu University ยท Tests: GAIA-102, GAIA-102, Pembrolizumab, Pembrolizumab, Trifluridine/tipiracil hydrochloride (FTD/TPI) Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor Necrosis Factor or Bevacizumab for the Treatment of Malignant Ascites Following Failure of Prior Standard Therapy NCT07397819Phase 1, Phase 21 site๐Ÿ“ Guangzhou Dong sheng Zhang ยท Tests: liposomal irinotecan monotherapy, liposomal irinotecan monotherapy, Liposomal Irinotecan + rmhTNF-NC, Liposomal Irinoteโ€ฆ A Phase I Study of SIM0388 in Participants With Malignant Ascites. NCT07007988Phase 11 site๐Ÿ“ Shanghai Jiangsu Simcere Pharmaceutical Co., Ltd. ยท Tests: SIM0388, SIM0388 The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites NCT06433869Phase 23 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: serplulimab, Bevacizumab, rmhTNF-NC Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer NCT06016179Phase 11 site๐Ÿ“ Pittsburgh Allegheny Singer Research Institute (also known as Alleghenโ€ฆ ยท Tests: Tocilizumab TLR9 Immunotherapy for Peritoneal Carcinomatosis NCT07658196Phase 11 site๐Ÿ“ Providence Brown University ยท Tests: ACM-CpG Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors NCT04684459EARLY Phase 11 site๐Ÿ“ Chengdu Sichuan University ยท Tests: Dual-targeting HER2 and PD-L1 CAR-T cells
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy